JPWO2021033766A1 - - Google Patents

Info

Publication number
JPWO2021033766A1
JPWO2021033766A1 JP2021540988A JP2021540988A JPWO2021033766A1 JP WO2021033766 A1 JPWO2021033766 A1 JP WO2021033766A1 JP 2021540988 A JP2021540988 A JP 2021540988A JP 2021540988 A JP2021540988 A JP 2021540988A JP WO2021033766 A1 JPWO2021033766 A1 JP WO2021033766A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540988A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021033766A1 publication Critical patent/JPWO2021033766A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021540988A 2019-08-22 2020-08-21 Pending JPWO2021033766A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019151943 2019-08-22
PCT/JP2020/031642 WO2021033766A1 (ja) 2019-08-22 2020-08-21 ビタミンd活性を有するリトコール酸誘導体

Publications (1)

Publication Number Publication Date
JPWO2021033766A1 true JPWO2021033766A1 (de) 2021-02-25

Family

ID=74661161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540988A Pending JPWO2021033766A1 (de) 2019-08-22 2020-08-21

Country Status (2)

Country Link
JP (1) JPWO2021033766A1 (de)
WO (1) WO2021033766A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
JP2019055913A (ja) * 2016-01-28 2019-04-11 国立大学法人お茶の水女子大学 ビタミンd活性を有するリトコール酸誘導体
CN109364084A (zh) * 2018-11-27 2019-02-22 深圳市绘云生物科技有限公司 一种治疗血糖、血脂异常及神经退行性疾病的药物及其制剂

Also Published As

Publication number Publication date
WO2021033766A1 (ja) 2021-02-25

Similar Documents

Publication Publication Date Title
BR112019017762A2 (de)
BR112021017339A2 (de)
BR112021013854A2 (de)
BR112021017939A2 (de)
BR112021017892A2 (de)
BR112019016141A2 (de)
BR112021017738A2 (de)
BR112021017782A2 (de)
BR112019016142A2 (de)
BR112019016138A2 (de)
BR112021017728A2 (de)
AU2020104490A5 (de)
BR112021008711A2 (de)
BR112021017234A2 (de)
BR112021017355A2 (de)
BR112021017703A2 (de)
BR112021017173A2 (de)
BR112021018584A2 (de)
BR112021017083A2 (de)
BR112021017637A2 (de)
BR112021015080A2 (de)
BR112021012348A2 (de)
BR112021013944A2 (de)
BR112021013128A2 (de)
BR112021017732A2 (de)

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20220216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220218

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20220317

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240521